Legal Representation
Attorney
Robert B.G. Horowitz, Esq.
USPTO Deadlines
Next Deadline
1239 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-12-06)
Due Date
December 06, 2028
Grace Period Ends
June 06, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 6, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 6, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Sep 20, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 20, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 31, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 17, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 16, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Aug 16, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 16, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 16, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jul 8, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 8, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 7, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jun 22, 2022 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| May 26, 2022 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| May 26, 2022 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| May 26, 2022 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Nov 26, 2021 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Nov 26, 2021 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Nov 26, 2021 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Nov 14, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 2, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 14, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 009
Recorded and downloadable computer software for use by the healthcare and life sciences business sectors for analyzing patient and clinical trial data in order to support pharmaceutical research and development and to improve direct patient care by providing predictive models to aid physicians in stratifying patients and making appropriate medical interventions for their treatment through the use of algorithms
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Designing and developing computer software containing algorithms for use by the healthcare and life sciences business sectors for the purpose of analyzing patient and clinical trial data in order to support pharmaceutical research and development and to improve direct patient care by providing predictive models to aid physicians in stratifying patients and making appropriate medical interventions for their treatment; Software as a Service (SAAS) services in the form of computer software for use by the healthcare and life sciences business sectors for the purpose of analyzing patient and clinical trial data in order to support pharmaceutical research and development and to improve direct patient care by providing predictive models to aid physicians in stratifying patients and making appropriate medical interventions for their treatment through the use of algorithms; Algorithms as a service (AAAS), namely, on-line, non-downloadable software containing algorithms from a cloud-based platform for the design of computer software and computer programming for third-parties in the healthcare and life sciences business sectors for the purpose of analyzing patient and clinical trial data to support pharmaceutical research and development and to improve direct patient care by providing predictive models to aid physicians in stratifying patients and making appropriate medical interventions for their treatment
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
009
042